[Effects of chronic administration of several calcium antagonists on pituitary release of TSH].
Custro
N
N
Scafidi
V
V
D000328:Adult; D001262:Atenolol / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009529:Nicardipine / Q000494:pharmacology; D009543:Nifedipine / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D011897:Random Allocation; D013972:Thyrotropin / Q000097:blood*; D013997:Time Factors; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D001262:Atenolol; D013972:Thyrotropin; D014700:Verapamil; D009529:Nicardipine; D009543:Nifedipine
Effetti della somministrazione cronica di alcuni calcioantagonisti sul rilascio ipofisario del TSH.